Data / Form D filings / Foldax, Inc.
Foldax, Inc.: Form D filings
Foldax, Inc., a biotechnology company in Salt Lake City, UT, filed 11 Form D notices with the SEC between 2014 and 2023. The latest, on November 7, 2023, reports $7 million sold of an offering with no set size to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 825 N 300 W, Salt Lake City, UT, 84103
- Phone
- (626) 344-9665
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1602708
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 7, 2023 | New notice | Indefinite | $7,000,000 | 10 | Oct 18, 2023 | sec.gov | |
| Jan 13, 2022 | New notice | $15,000,000 | $0 | $15,000,000 | 0 | Yet to occur | sec.gov |
| Dec 19, 2018 | New notice | $10,300,118 | $10,300,118 | 15 | Dec 12, 2018 | sec.gov | |
| May 12, 2017 | New notice | $9,000,000 | $300,000 | $8,700,000 | 1 | Apr 3, 2017 | sec.gov |
| Jul 26, 2016 | New notice | $3,075,000 | $3,075,000 | 9 | Jul 15, 2016 | sec.gov | |
| Sep 8, 2015 | New notice | $2,500,000 | $2,500,000 | 1 | Aug 28, 2015 | sec.gov | |
| Jun 16, 2015 | New notice | $1,500,000 | $350,000 | $1,150,000 | 2 | Jun 8, 2015 | sec.gov |
| Aug 21, 2014 | Amendment | $4,750,000 | $50,000 | $4,700,000 | 1 | Aug 14, 2014 | sec.gov |
| Aug 21, 2014 | New notice | $4,750,000 | $50,000 | $4,700,000 | 1 | Aug 14, 2014 | sec.gov |
| Apr 21, 2014 | New notice | $1,500,000 | $150,000 | $1,350,000 | 3 | Mar 26, 2014 | sec.gov |
| Mar 18, 2014 | New notice | $15,000 | $15,000 | 2 | Feb 26, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Scott Huennekens | Director | |
| Ken Charhut | Director | |
| Jim Demetriades | Director | |
| Scott Richland | Director | |
| George Wallace | Director | |
| Greg Casciaro | Executive Officer, Director | |
| Brant Heise | Director |
Other biotechnology companies in Utah that filed recently
- Life Impact Partners 1 LLC offering · Oct 22, 2026
- 3Helix, Inc. $7.8 million · Sep 21, 2026
- Halia Therapeutics, Inc. $3.5 million · Aug 31, 2026
- Paterna BioSciences HoldCo Inc. $6.3 million · Aug 12, 2026
Every Form D from the week of Nov 6, 2023 · All recent filings in Utah · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Foldax, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.